Teva plans to close Montreal plant

Teva Pharmaceutical Industries will divest itself of a Montreal-based plant it inherited from its buyout of Ratiopharm last year. The plant, which employs 340 people, has already been put up for sale. But if no buyers emerge, layoffs will begin next March. Report

Suggested Articles

Merck’s Keytruda already boasts an OK in some esophageal cancer patients, but it’s looking to widen its reach in the tough-to-treat disease..

GI cancers are stubborn, as plenty of oncology drugmakers know. But BMS' Opidivo has broken through with two potentially practice-changing trials.

The custodial measure came after Chinese customs officials raided Genscript’s businesses for “suspected violations of import and export regulations.”